Can we optimise doxorubicin treatment regimens for children with cancer? Pharmacokinetic simulations and a Delphi consensus procedure

Abstract Background Despite its cardiotoxicity doxorubicin is widely used for the treatment of paediatric malignancies. Current treatment regimens appear to be suboptimal as treatment strategies vary and do not follow a clear pharmacological rationale. Standardisation of dosing strategies in particu...

全面介紹

書目詳細資料

發表在:	BMC Pharmacology and Toxicology
Main Authors:	Christian Siebel, Gudrun Würthwein, Claudia Lanvers-Kaminsky, Nicolas André, Frank Berthold, Ilaria Castelli, Pascal Chastagner, François Doz, Martin English, Gabriele Escherich, Michael C. Frühwald, Norbert Graf, Andreas H. Groll, Antonio Ruggiero, Georg Hempel, Joachim Boos
格式:	Article
語言:	英语
出版:	BMC 2020-05-01
主題:	Doxorubicin Children Cardiotoxicity Pharmacokinetics Delphi procedure
在線閱讀:	http://link.springer.com/article/10.1186/s40360-020-00417-2